cancer antibody drug conjugates market

Global Cancer Antibody Drug Conjugates Market Analysis 2016-2020 and Forecast 2021-2026

  • Published Date: 2021-03-31
  • Report ID: 89022
  • Pages: 90
  • Format: prudent report format

Prudent Markets

The global Cancer Antibody Drug Conjugates market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Cancer Antibody Drug Conjugates by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
First & Second Generation ADCs
Third Generation ADCs

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Novartis
Merck
Roche
AbbVie
UCB
Bristol-Myers Squibb
Stem CentRx
Biogen Idec
Nordic Nanovector
Millennium
Biotest AG
PDL BioPharma
Progenics Pharmaceuticals
Seattle Genetics
Viventia Biotechnologies
AbGenomics Corporation
Helix BioPharma

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospitals
Clinics
Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)


Table of Contents
Table of Contents
1 Industry Overview
1.1 Cancer Antibody Drug Conjugates Industry
Figure Cancer Antibody Drug Conjugates Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Cancer Antibody Drug Conjugates
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Cancer Antibody Drug Conjugates
1.2.2 Downstream
Table Application Segment of Cancer Antibody Drug Conjugates
Table Global Cancer Antibody Drug Conjugates Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Cancer Antibody Drug Conjugates Market by Type
3.1 By Type
3.1.1 First & Second Generation ADCs
Table Major Company List of First & Second Generation ADCs
3.1.2 Third Generation ADCs
Table Major Company List of Third Generation ADCs
3.2 Market Size
Table Global Cancer Antibody Drug Conjugates Market 2016-2020, by Type, in USD Million
Figure Global Cancer Antibody Drug Conjugates Market Growth 2016-2020, by Type, in USD Million
Table Global Cancer Antibody Drug Conjugates Market 2016-2020, by Type, in Volume
Figure Global Cancer Antibody Drug Conjugates Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Cancer Antibody Drug Conjugates Market Forecast 2021-2026, by Type, in USD Million
Table Global Cancer Antibody Drug Conjugates Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Novartis (Company Profile, Sales Data etc.)
4.1.1 Novartis Profile
Table Novartis Overview List
4.1.2 Novartis Products & Services
4.1.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Merck (Company Profile, Sales Data etc.)
4.2.1 Merck Profile
Table Merck Overview List
4.2.2 Merck Products & Services
4.2.3 Merck Business Operation Conditions
Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Roche (Company Profile, Sales Data etc.)
4.3.1 Roche Profile
Table Roche Overview List
4.3.2 Roche Products & Services
4.3.3 Roche Business Operation Conditions
Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 AbbVie (Company Profile, Sales Data etc.)
4.4.1 AbbVie Profile
Table AbbVie Overview List
4.4.2 AbbVie Products & Services
4.4.3 AbbVie Business Operation Conditions
Table Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 UCB (Company Profile, Sales Data etc.)
4.5.1 UCB Profile
Table UCB Overview List
4.5.2 UCB Products & Services
4.5.3 UCB Business Operation Conditions
Table Business Operation of UCB (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Bristol-Myers Squibb (Company Profile, Sales Data etc.)
4.6.1 Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Overview List
4.6.2 Bristol-Myers Squibb Products & Services
4.6.3 Bristol-Myers Squibb Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Stem CentRx (Company Profile, Sales Data etc.)
4.7.1 Stem CentRx Profile
Table Stem CentRx Overview List
4.7.2 Stem CentRx Products & Services
4.7.3 Stem CentRx Business Operation Conditions
Table Business Operation of Stem CentRx (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Biogen Idec (Company Profile, Sales Data etc.)
4.8.1 Biogen Idec Profile
Table Biogen Idec Overview List
4.8.2 Biogen Idec Products & Services
4.8.3 Biogen Idec Business Operation Conditions
Table Business Operation of Biogen Idec (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Nordic Nanovector (Company Profile, Sales Data etc.)
4.9.1 Nordic Nanovector Profile
Table Nordic Nanovector Overview List
4.9.2 Nordic Nanovector Products & Services
4.9.3 Nordic Nanovector Business Operation Conditions
Table Business Operation of Nordic Nanovector (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Millennium (Company Profile, Sales Data etc.)
4.10.1 Millennium Profile
Table Millennium Overview List
4.10.2 Millennium Products & Services
4.10.3 Millennium Business Operation Conditions
Table Business Operation of Millennium (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Biotest AG (Company Profile, Sales Data etc.)
4.11.1 Biotest AG Profile
Table Biotest AG Overview List
4.11.2 Biotest AG Products & Services
4.11.3 Biotest AG Business Operation Conditions
Table Business Operation of Biotest AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 PDL BioPharma (Company Profile, Sales Data etc.)
4.12.1 PDL BioPharma Profile
Table PDL BioPharma Overview List
4.12.2 PDL BioPharma Products & Services
4.12.3 PDL BioPharma Business Operation Conditions
Table Business Operation of PDL BioPharma (Sales Revenue, Cost, Gross Margin)
4.13 Progenics Pharmaceuticals (Company Profile, Sales Data etc.)
4.13.1 Progenics Pharmaceuticals Profile
Table Progenics Pharmaceuticals Overview List
4.13.2 Progenics Pharmaceuticals Products & Services
4.13.3 Progenics Pharmaceuticals Business Operation Conditions
Table Business Operation of Progenics Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Seattle Genetics (Company Profile, Sales Data etc.)
4.14.1 Seattle Genetics Profile
Table Seattle Genetics Overview List
4.14.2 Seattle Genetics Products & Services
4.14.3 Seattle Genetics Business Operation Conditions
Table Business Operation of Seattle Genetics (Sales Revenue, Cost, Gross Margin)
4.15 Viventia Biotechnologies (Company Profile, Sales Data etc.)
4.15.1 Viventia Biotechnologies Profile
Table Viventia Biotechnologies Overview List
4.15.2 Viventia Biotechnologies Products & Services
4.15.3 Viventia Biotechnologies Business Operation Conditions
Table Business Operation of Viventia Biotechnologies (Sales Revenue, Cost, Gross Margin)
4.16 AbGenomics Corporation (Company Profile, Sales Data etc.)
4.16.1 AbGenomics Corporation Profile
Table AbGenomics Corporation Overview List
4.16.2 AbGenomics Corporation Products & Services
4.16.3 AbGenomics Corporation Business Operation Conditions
Table Business Operation of AbGenomics Corporation (Sales Revenue, Cost, Gross Margin)
4.17 Helix BioPharma (Company Profile, Sales Data etc.)
4.17.1 Helix BioPharma Profile
Table Helix BioPharma Overview List
4.17.2 Helix BioPharma Products & Services
4.17.3 Helix BioPharma Business Operation Conditions
Table Business Operation of Helix BioPharma (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Cancer Antibody Drug Conjugates Sales Revenue 2016-2020, by Company, in USD Million
Table Global Cancer Antibody Drug Conjugates Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Cancer Antibody Drug Conjugates Sales Revenue Share in 2020, by Company, in USD Million
Table Global Cancer Antibody Drug Conjugates Sales Volume 2016-2020, by Company, in Volume
Table Global Cancer Antibody Drug Conjugates Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Cancer Antibody Drug Conjugates Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Cancer Antibody Drug Conjugates Market Concentration, in 2020
Figure Europe Cancer Antibody Drug Conjugates Market Market Concentration, in 2020
Figure Asia-Pacific Cancer Antibody Drug Conjugates MMarket Concentration, in 2020
Figure South America Cancer Antibody Drug Conjugates Market Concentration, in 2020
Figure Middle East & Africa Cancer Antibody Drug Conjugates Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospitals
Figure Cancer Antibody Drug Conjugates Demand in Hospitals, 2016-2020, in USD Million
Figure Cancer Antibody Drug Conjugates Demand in Hospitals, 2016-2020, in Volume
6.1.2 Demand in Clinics
Figure Cancer Antibody Drug Conjugates Demand in Clinics, 2016-2020, in USD Million
Figure Cancer Antibody Drug Conjugates Demand in Clinics, 2016-2020, in Volume
6.1.3 Demand in Others
Figure Cancer Antibody Drug Conjugates Demand in Others, 2016-2020, in USD Million
Figure Cancer Antibody Drug Conjugates Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Cancer Antibody Drug Conjugates Demand Forecast 2021-2026, by Application, in USD Million
Figure Cancer Antibody Drug Conjugates Market Growth 2021-2026, by Application, in USD Million
Figure Cancer Antibody Drug Conjugates Market Share in 2026, by Application, in USD Million
Table Cancer Antibody Drug Conjugates Demand Forecast 2021-2026, by Application, in Volume
Table Cancer Antibody Drug Conjugates Market Growth 2021-2026, by Application, in Volume
Table Cancer Antibody Drug Conjugates Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Cancer Antibody Drug Conjugates Production 2016-2020, by Region, in USD Million
Table Cancer Antibody Drug Conjugates Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Cancer Antibody Drug Conjugates Market 2016-2020, by Region, in USD Million
Table Global Cancer Antibody Drug Conjugates Market Share 2016-2020, by Region, in USD Million
Table Global Cancer Antibody Drug Conjugates Market 2016-2020, by Region, in Volume
Table Global Cancer Antibody Drug Conjugates Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Cancer Antibody Drug Conjugates Market Size and Growth 2016-2020, in USD Million
Figure North America Cancer Antibody Drug Conjugates Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Cancer Antibody Drug Conjugates Market Size 2016-2020, by Country, in USD Million
Table North America Cancer Antibody Drug Conjugates Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Cancer Antibody Drug Conjugates Market Size and Growth 2016-2020, in USD Million
Figure Europe Cancer Antibody Drug Conjugates Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Cancer Antibody Drug Conjugates Market Size 2016-2020, by Country, in USD Million
Table Europe Cancer Antibody Drug Conjugates Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Cancer Antibody Drug Conjugates Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Cancer Antibody Drug Conjugates Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Cancer Antibody Drug Conjugates Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Cancer Antibody Drug Conjugates Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Cancer Antibody Drug Conjugates Market Size and Growth 2016-2020, in USD Million
Figure South America Cancer Antibody Drug Conjugates Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Cancer Antibody Drug Conjugates Market Size 2016-2020, by Country, in USD Million
Table South America Cancer Antibody Drug Conjugates Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Cancer Antibody Drug Conjugates Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Cancer Antibody Drug Conjugates Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Cancer Antibody Drug Conjugates Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Cancer Antibody Drug Conjugates Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Cancer Antibody Drug Conjugates Market Forecast 2021-2026, by Region, in USD Million
Table Cancer Antibody Drug Conjugates Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.